Health
UK regulator speeds process to OK coronavirus vaccines for new variants – POLITICO.eu
Oxford/AstraZeneca has said it has begun making a version of its vaccine against a novel variant.
The U.K.s drugs regulator won’t require further large-scale clinical trials to approve modified coronavirus vaccines against new variants, it said on Thursday.
Instead of waiting to see if vaccinated people become infected, as is usually done, the Medicines and Healthcare products Regulatory Agency (MHRA) will require data that show new versions of approved vaccines induce an immune response through blood tests. These studies will be smaller and faster.
The MHRA has developed guidance for the pharmaceutical…
-
Noosa News7 hours agoHow Lily Steele-Park took her rapist to court and won
-
General21 hours ago‘Potential’ hacker contacts Qantas over data breach
-
Business12 hours agoFord CEO makes stunning prediction about artificial intelligence
-
Business22 hours ago5 amazing ASX ETFs for Aussie investors in July